ARUP offers a comprehensive menu to assess patients with kidney stone disease.

Kidney stone formation and calculi testing graphic

Calculi (stone) testing specializes in two areas that provide valuable information to determine appropriate treatment and course of patient care:

  1. Assessing and monitoring the risk of stone formation (urine studies)
  2. Evaluating stone composition

Epidemiology

  • It is estimated that 1 in 10 individuals will develop kidney stones in their lives.
  • The risk of kidney stones is around 9% in women and 11% in men in the United States.
  • For those individuals who have experienced kidney stones, there is a 50% increased risk of additional development within 5 to 7 years.
  • Incidence of this disease is rising and estimated to cost $5.3 billion per year in healthcare dollars.

Test Information

Calculi testing and kidney stone composition

Benefits of Calculi Testing at ARUP

  • ARUP has designed efficient urine panels that assess stone-forming risk, monitor the course of therapy, and reduce testing expenses (ARUP test codes 2008771, 2008708, 0020843).
  • ARUP has developed in-house technology for stone processing, which reduces errors and decreases turnaround time.
  • A full stone analysis with a photo is available through ARUP’s enhanced reporting system.
  • Enhanced graphical reports are available for Calculi Risk Assessment (2008708), Supersaturation Profile (2008771), and Calculi (Stone) Analysis with Photo (2005231).

View related ARUP testing

Resources